BioMarin Pharmaceutical Inc. (BMRN) PT Set at $116.00 by Jefferies Group LLC

Ameritas Investment Partners Inc. now owns 3,126 shares of the biotechnology company’s stock valued at $284,000 after buying an additional 54 shares in the last quarter. Diamondback Energy Inc now has $8.71B valuation. The stock increased 0.94% or $1.4 during the last trading session, reaching $149.65. About 44,981 shares traded. TCG BDC Inc (NASDAQ:CGBD) has 0.00% since August 27, 2016 and is. It has outperformed by 9.66% the S&P500. The correct version of this piece can be read at https://stocknewstimes.com/2017/08/27/biomarin-pharmaceutical-inc-bmrn-pt-set-at-116-00-by-jefferies-group-llc.html.

BioMarin Pharmaceutical Inc is a biotechnology company. The Blue Ridge Capital Llc holds 595,000 shares with $49.29M value, down from 800,000 last quarter. Biomarin Pharmaceuticals now has $14.35B valuation. UBS Asset Management Americas Inc. now owns 1,087,995 shares of the biotechnology company’s stock worth $95,504,000 after buying an additional 110,504 shares in the last quarter.

BioMarin Pharmaceutical (NASDAQ:BMRN) last announced its quarterly earnings results on Wednesday, August 2nd. Therefore 71% are positive. The Home Depot Inc. has $182 highest and $106 lowest target. The Home Depot Inc. had 70 analyst reports since August 19, 2015 according to SRatingsIntel. The rating was maintained by Barclays Capital on Friday, February 26 with “Overweight”. RBC Capital Markets has “Buy” rating and $145 target. The firm earned “Buy” rating on Tuesday, August 15 by Oppenheimer. As per Thursday, November 5, the company rating was maintained by Northland Capital. As per Tuesday, July 18, the company rating was maintained by BMO Capital Markets. The stock has “Buy” rating by Longbow on Friday, August 14. Visa Inc (Put) (NYSE:V) was raised too. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, February 16. Spark Ltd invested 0.02% in ARI Network Services, Inc. Its up 0.08, from 0.8 in 2016Q3. 61 funds opened positions while 163 raised stakes. Creative Planning stated it has 2,099 shares or 0% of all its holdings. Bbt Capital Management Ltd reported 11,291 shares. Girard Ptnrs Ltd has invested 1.66% in Home Depot Inc (NYSE:HD).

BioMarin Pharmaceutical Inc is a biotechnology company. Ruggie Cap Gp Inc holds 421 shares. Tfs Capital Ltd Limited Liability Company has 4,426 shares for 0.1% of their portfolio. Qs Invsts Ltd holds 7,204 shares. Manning Napier Limited Liability, a New York-based fund reported 2.03 million shares. Eagle Asset has 561,816 shares for 0.5% of their portfolio. 67,042 are held by Davenport & Ltd Company. Marshall And Sullivan Inc Wa holds 4.37% or 26,781 shares. 32,358 were reported by Utd Automobile Association. 206,605 are held by Apg Asset Mgmt Nv. Panagora Asset Mngmt has 4,566 shares. Riverhead Capital Management Llc acquired 43,796 shares as Express Scripts Holding Co (ESRX)’s stock declined 14.09%. Vanguard Group Inc. now owns 13,702,404 shares of the biotechnology company’s stock valued at $1,202,796,000 after buying an additional 495,118 shares in the last quarter. HOLIFIELD MARK had sold 48,769 shares worth $7.65 million on Wednesday, May 17. BIENAIME JEAN JACQUES sold $437,650 worth of BioMarin Pharmaceutical Inc. The total value of its holdings increased 1,718.6%.

Several large investors have recently added to or reduced their stakes in BMRN. The biotechnology company reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.01. Cornerstone Cap Mgmt Hldgs Limited Liability Corporation reported 4,916 shares or 0% of all its holdings. Great West Life Assurance Communication Can stated it has 89,025 shares or 0.02% of all its holdings. The SI to CR Bard Incorporated’s float is 0.94%. Aperio Group Ltd holds 0.07% of its portfolio in C R Bard Inc (NYSE:BCR) for 39,712 shares. Winslow Evans & Crocker reported 78 shares stake. Highland Capital Mngmt Limited Partnership reported 20,289 shares. Baker Bros LP has invested 3.9% in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Geode Management Limited Liability has invested 0.05% in BioMarin Pharmaceutical Inc.

Several equities research analysts have recently commented on BMRN shares. Northern Trust reported 0.03% stake. Scotia accumulated 10,489 shares. Kanaly has invested 0% of its portfolio in BioMarin Pharmaceutical Inc. Citigroup reported 179,511 shares. Commerzbank Aktiengesellschaft Fi holds 120,090 shares or 0.15% of its portfolio.

Among 24 analysts covering BioMarin Pharmaceutical (NASDAQ:BMRN), 16 have Buy rating, 0 Sell and 8 Hold. Sivik Global Lc invested 2.37% in BioMarin Pharmaceutical Inc. Insiders sold a total of 51,740 shares of company stock worth $4,759,039 over the last 90 days. On Friday, April 28 the insider Davis George Eric sold $250,853.

Rhenman & Partners Asset Management Ab decreased Biomarin Pharmaceutical Inc (BMRN) stake by 64.29% reported in 2016Q4 SEC filing. (BMRN) opened at 81.88 on Friday. The insider Mueller Brian sold $687,334. The firm earned “Outperform” rating on Monday, January 23 by Credit Suisse. $29,215 worth of stock was sold by Ajer Jeffrey Robert on Tuesday, May 2. On Tuesday, February 28 the insider SPIEGELMAN DANIEL K sold $3.29 million. BCR’s SI was 679,100 shares in August as released by FINRA. Therefore 27% are positive. BioMarin Pharmaceutical had a negative return on equity of 5.77% and a negative net margin of 15.54%. The stock of Diamondback Energy Inc (NASDAQ:FANG) earned “Equal-Weight” rating by Barclays Capital on Tuesday, August 8. (NASDAQ:BMRN) earned “Neutral” rating by PiperJaffray on Monday, November 7. The rating was downgraded by Canaccord Genuity to “Buy” on Thursday, February 18. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and fourteen have given a buy rating to the company. Wedbush maintained BioMarin Pharmaceutical Inc. Goldman Sachs upgraded the shares of BCR in report on Thursday, August 27 to “Neutral” rating. BioMarin Pharmaceutical presently has a consensus rating of Hold and an average target price of $109.73. The firm has “Outperform” rating given on Wednesday, January 20 by Credit Suisse. The stock has “Buy” rating by Stifel Nicolaus on Thursday, August 3. William Blair maintained BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) on Friday, June 16. Dynamic Technology Lab Private Ltd purchased a new stake in BioMarin Pharmaceutical during the second quarter valued at approximately $368,000. The rating was initiated by Evercore with “Buy” on Thursday, September 15.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *